<DOC>
	<DOCNO>NCT00730015</DOCNO>
	<brief_summary>The objective trial determine efficacy safety linaclotide administer patient chronic constipation ( CC ) . The primary efficacy parameter percentage patient dose group meet protocol definition Complete Spontaneous Bowel Movement ( CSBM ) Overall Responder .</brief_summary>
	<brief_title>Trial Linaclotide Patients With Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Patient complete colonoscopy accord AGA criterion , clinically significant finding Patient successfully complete protocol procedure ( clinically significant finding ) : physical exam , 12lead ECG , clinical laboratory test Patient meet protocol criterion CC : report &lt; 3 bowel movement per week report straining , lumpy hard stool , and/or sensation incomplete evacuation &gt; 25 % BMs Patient demonstrate continue chronic constipation Pretreatment Period Patient compliant IVRS Patient history loose watery stool Patient symptom diagnose Irritable Bowel Syndrome ( IBS ) Patient structural abnormality gastrointestinal ( GI ) tract disease condition affect GI motility Patient protocolexcluded clinically significant medical surgical history could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>